Scarica l'app Stockscreener
124.22
4.08%
-5.28
Pre-mercato:
123.01
-1.21
-0.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$129.50
Aprire:
$124.38
Volume 24 ore:
910.52K
Relative Volume:
1.77
Capitalizzazione di mercato:
$8.00B
Reddito:
$3.78B
Utile/perdita netta:
$392.50M
Rapporto P/E:
21.11
EPS:
5.8837
Flusso di cassa netto:
$294.56M
1 W Prestazione:
-5.91%
1M Prestazione:
-12.35%
6M Prestazione:
-7.64%
1 anno Prestazione:
-15.09%
Intervallo 1D:
$121.42
$126.58
Intervallo di 1 settimana:
$121.42
$132.79
Portata 52W:
$103.23
$164.28
Aptargroup Inc Stock (ATR) Company Profile
Nome
Aptargroup Inc
Settore
Industria
Telefono
(815) 477-0424
Indirizzo
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Compare ATR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATR
Aptargroup Inc
|
124.22 | 8.00B | 3.78B | 392.50M | 294.56M | 5.8837 |
|
ISRG
Intuitive Surgical Inc
|
477.73 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.08 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.74 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.26 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.88 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-11-03 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-09-04 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-01-07 | Iniziato | Raymond James | Outperform |
| 2025-01-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-10-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-04-29 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-01-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-08-02 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-04-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-10-14 | Iniziato | Seaport Global Securities | Neutral |
| 2020-04-27 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-03-25 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2020-03-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-02-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-07-08 | Iniziato | Morgan Stanley | Overweight |
| 2019-04-05 | Reiterato | BofA/Merrill | Underperform |
| 2019-02-27 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-05-18 | Iniziato | Jefferies | Hold |
| 2016-12-07 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2016-10-13 | Iniziato | Jefferies | Hold |
| 2016-01-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2015-11-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2015-09-15 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2015-05-01 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2013-02-19 | Reiterato | Deutsche Bank | Hold |
| 2013-01-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2012-07-10 | Downgrade | KeyBanc Capital Mkts | Buy → Hold |
| 2012-04-11 | Iniziato | KeyBanc Capital Mkts | Buy |
| 2011-06-13 | Aggiornamento | KeyBanc Capital Mkts | Hold → Buy |
Mostra tutto
Aptargroup Inc Borsa (ATR) Ultime notizie
AptarGroup (NYSE: ATR) executive uses 273 shares to cover taxes - Stock Titan
[Form 4] APTARGROUP, INC. Insider Trading Activity - Stock Titan
AptarGroup (NYSE: ATR) CFO reports routine 368-share tax withholding - Stock Titan
AptarGroup (NYSE: ATR) exec has shares withheld for taxes - Stock Titan
AptarGroup (NYSE: ATR) CLO uses 37 shares for tax withholding - Stock Titan
AptarGroup Appoints Gael Touya as President & CEO Effective September 1, 2026 - Minichart
Aptar appoints Gael Touya as CEO - MSN
AptarGroup Hires New CEO - Benzinga
AptarGroup Hires New CEO - Benzinga
AptarGroup Inc Stock (ISIN: US0383361039) Faces Headwinds Amid CEO Succession and Analyst Downgrade - AD HOC NEWS
Aptar Announces Gael Touya as its Next Chief Executive Officer Stephan B. Tanda to Retire by the End of the Year - Aptar
AptarGroup names Gael Touya as next CEO, effective September By Investing.com - Investing.com Canada
AptarGroup CEO Stephan Tanda to retire, Gael Touya named successor - Investing.com
AptarGroup CEO Stephan Tanda to retire, Gael Touya named successor By Investing.com - Investing.com India
AptarGroup Announces CEO Succession and Leadership Transition Plan - TipRanks
AptarGroup names Gael Touya as next CEO, effective September - Investing.com
AptarGroup (ATR) Announces New CEO Appointment - GuruFocus
AptarGroup (NYSE: ATR) taps Gael Touya as CEO, sets new pay deals - Stock Titan
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year - Bluefield Daily Telegraph
AptarGroup (ATR) Segment President reports tax-withholding of 677 shares - Stock Titan
AptarGroup (NYSE: ATR) CEO uses 3,455 shares for tax withholding - Stock Titan
AptarGroup (ATR) President reports 481-share tax withholding - Stock Titan
APTARGROUP (ATR) EVP uses 72 shares to cover tax obligations in Form 4 - Stock Titan
Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray - Aptar
Experimental nasal erectile dysfunction drug tests Aptar’s delivery tech - Stock Titan
Aug Gainers: Can AptarGroup Inc be recession proofDividend Hike & Low Drawdown Trading Techniques - baoquankhu1.vn
ATRAptargroup Latest Stock News & Market Updates - Stock Titan
Crawford Investment Counsel Inc. Grows Position in AptarGroup, Inc. $ATR - MarketBeat
Brown Brothers Harriman & Co. Has $53.62 Million Stake in AptarGroup, Inc. $ATR - MarketBeat
Aptar and Covirix Medical collaborate on inhaled antivirals - BioWorld MedTech
Schroder Investment Management Group Cuts Holdings in AptarGroup, Inc. $ATR - MarketBeat
Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments - pharmiweb.com
Natixis Advisors LLC Sells 20,038 Shares of AptarGroup, Inc. $ATR - MarketBeat
First Trust Advisors LP Grows Stock Position in AptarGroup, Inc. $ATR - MarketBeat
Dimensional Fund Advisors LP Grows Position in AptarGroup, Inc. $ATR - MarketBeat
Jobs Data: Is AptarGroup Inc a stock for growth or value investorsTrade Exit Summary & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
AptarGroup Isn't Ready For An Upgrade Just Yet (NYSE:ATR) - Seeking Alpha
Trigger Sprayers Market Set for Dynamic Boom as Key Players AptarGroup Inc. • Berry Global Inc. • Silgan Holdings Inc - openPR.com
Sentiment Watch: How correlated is AptarGroup Inc to the S P5002026 Risk Factors & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
AptarGroup, Inc. (NYSE:ATR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
AptarGroup, Inc. $ATR Shares Bought by Aptus Capital Advisors LLC - MarketBeat
AptarGroup declares $0.48 dividend - MSN
AptarGroup declares $0.45 dividend - MSN
GW&K Investment Management LLC Has $37.79 Million Stock Holdings in AptarGroup, Inc. $ATR - MarketBeat
AptarGroup, Inc. (ATR) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow - Seeking Alpha
AptarGroup, Inc. (ATR) Stock Price Today | Live Chart & News - Traders Union
Live AptarGroup, Inc. (ATR) Technical Analysis - Traders Union
ATR SEC FilingsAptargroup 10-K, 10-Q, 8-K Forms - Stock Titan
ATR Technical Analysis & Stock Price Forecast - Intellectia AI
Victory Capital Management Inc. Cuts Position in AptarGroup, Inc. $ATR - MarketBeat
AptarGroup, Inc. $ATR Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Aptargroup Inc Azioni (ATR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.29%
0.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):